Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
Glenmark Pharmaceuticals receives ANDA approval for Indomethacin Extended-Release Capsules USP, 75 mg
June 27, 2017
June 22, 2017
Glenmark Pharmaceuticals receives tentative ANDA approval for Solifenacin Succinate Tablets, 5 mg and 10 mg
June 21, 2017
Glenmark Pharmaceuticals Licenses Small Molecule Oncology Compound from APC Therapeutics to Expand Immuno-Oncology Portfolio
June 20, 2017